PT - JOURNAL ARTICLE AU - Dana M. Lapato AU - Roxann Roberson-Nay AU - Patricia A. Kinser AU - Timothy P. York TI - Predictive validity of a DNA methylation-based screening panel for postpartum depression AID - 10.1101/2020.03.05.20027847 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.05.20027847 4099 - http://medrxiv.org/content/early/2020/03/08/2020.03.05.20027847.short 4100 - http://medrxiv.org/content/early/2020/03/08/2020.03.05.20027847.full AB - Prenatal maternal depression increases the risk of negative maternal-infant health outcomes but often goes unrecognized. As a result, biomarker screening tests capable of identifying women at risk for depression are highly desirable. This study tested how demographic and clinical factors affect the predictive validity of a DNA methylation-based screening test for postpartum major depression (MD) using data from a longitudinal study of birth outcomes. Lifetime history of MD and current levels of postpartum depressive symptoms were assessed using an extended self-report version of the Composite International Diagnostic Interview Short Form and the Edinburgh Postnatal Depression Scale (EPDS), respectively. Predictive validity of the test was estimated in the PREG cohort using the area under the receiver operator characteristic curve (AUC), and sensitivity analyses were performed to assess the impact of self-reported race, age, and pre-pregnancy history of MD. Data for N=103 pregnant participants (African-American=49; European-American=54) were available. The prediction model identified women who would develop high levels of postpartum depressive symptoms better within the subset of women with previous histories of MD (AUC = 0.94, 95% CI 0.79-1.00) compared to the full pregnant cohort (AUC = 0.62, 95% CI 0.46-0.79). This observation prompted secondary analyses to test the model specificity for postpartum depression. The model predicted lifetime history of MD moderately well in never-pregnant, mixed-sex cohort of adolescents (N=150; ages 15-20; AUC = 0.75, 95% CI 0.57-0.92) and performed slightly better in males versus females. Additional sensitivity analyses are needed to determine the extent of the model’s specificity for MD subtypes and if demographic or clinical factors influence the predictive validity of this model.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Pregnancy, Race, Environment, Genes (PREG) longitudinal study and its postpartum extension were supported by the NIHMD (P60MD002256, PI: York, Strauss), The John and Polly Sparks Foundation and Brain and Behavior Research Foundation (24712, PI: York), American Nurses Foundation Research Grant (5232, PI: Kinser), Virginia Commonwealth University Center for Clinical and Translational Research Endowment Fund (6-40595, PI: Kinser). The Adolescent and Young Adult Twin Study was supported by a NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation and by the NIMH (R01MH101518) to RRN. DL is supported by NIMH T32MH020030 (PI: M. Neale). Both studies used REDCap to administer self-report questionnaires, and the use of REDCap was supported by Clinical and Translational Science Award (CTSA) award No. UL1TR000058 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe preregistration document and R code used to analyze the data and generate figures is available on the Open Science Framework (OSF) project landing page (https://osf.io/7dsf9). Data sharing from the Pregnancy, Race, Environment, Genes (PREG) study and Adolescent and Young Adult Twin Study are limited by Institutional Review Board (IRB) agreements and participant consent forms, which restrict openly sharing individual-level DNA methylation measures. Individuals interested in PREG or AYATS data access or collaboration are encouraged to contact Dr. Timothy P. York (timothy.york{at}vcuhealth.org) or Dr. Roxann Roberson-Nay (roxann.robersonnay{at}vcuhealth.org), respectively. https://osf.io/7dsf9 AUCArea under the curveAYATSAdolescent and Young Adult Twin StudyDNAmDNA methylationEPDSEdinburgh Postnatal Depression ScaleMDMajor depressionMDPMajor depression in the peripartumMZMonozygoticPPDPostpartum depressionPREGPregnancy, Race, Environment, Genes StudyROCReceiver operator characteristic